New study by Professor Yoon-Kyoung Cho validates urine-based biomarkers for early detection of cancer.
A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science at UNIST has recently developed a new technique that effectively identifies cancer-causing substances in the urine or blood.
In the study, Professor Yoon-Kyoung Cho of Life Science, a group leader at IBS Research Center for Soft and Living Matter (CSLM) presented an integrated centrifugal microfluidic
platform (Exodisc), a device that isolates extracellular vesicles (EVs) from urine.
The results of the study has been published in the February issue of ACS Nano journal. The research team expects that this may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics.
Despite the increasing clinical importance of EVs as potential biomarkers in the diagnosis and prognosis of various diseases, current methods of EV isolation and analysis suffer from complicated procedures with long processing times. For instance, even ultracentrifugation (UC), the most commonly used method for EV isolation, requires time-consuming steps involving centrifugation and acquisition of large sample volumes, and the results suffer from low yield and purity.
To overcome these limitations, Professor Cho presented a new lab-on-a-disc platform for rapid, size-selective, and efficient isolation and analysis of nanoscale EVs from raw biological samples, such as cell-culture supernatant (CCS) or cancer-patient urine.
“The Exodisc is compoased of two independent filteration units (20nm and 600nm in size) within a disk-shaped chip to enable the processing of two different samples simulateously,” says Hyun-Kyung Woo (Combined M.S./Ph.D. student of Natural Science), the first author of the study. “Upon spinning the disc, the urine sample is transferred through two integrated nanofilters, allowing for the enrichment of unirary EVs within the size range of 20 to 600 nm.”
The hole sizes in nanoporous filters mounted on the Exodisc were set arbitrarily to seperate the nanoscale vesicles effectively from germs or unnecessary proteins. The direct detection of urinary EVs from patients with bladder cancer was validated successfully, using on-disc enzyme-linked immunosorbent assay (ELISA).
“Using Exodisc, it is possible to isolate EVs from raw samples within 30 minutes,” says Professor Cho. “The process of passing the filter through centrifugal force is automatically carried out, effectively recovering the enriched EVs.”
In the study, the research team examined clinical samples by analyzing urinary EVs from bladder cancer patients, using a tabletop-sized centrifugal microfluidic system. As a result, fully automated enrichment of unirary EVs in the size range of 20?600 nm was achieved within 30 min Quantitative tests.
“On-disc ELISA using urinary EVs isolated from bladder cancer patients showed high levels of CD9 and CD81 expression, suggesting that this method may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics,” says Vijaya Sunkara of Life Sciences, the co-first author.
“We are currently conducting further studies to determine various diseases, including cancer by analyzing the collected nanoparticles,” says Professor Cho. “We hope this device can contribute significantly to the advancement of studies related to tumor biology and acceleration of the practical use of EV-based liquid biopsies for personalized medicine in clinical settings,” says Professor Cho.
Learn more: Urine-based Biomarkers for Early Cancer Screening Test
[osd_subscribe categories=’cancer-diagnostics’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “CANCER DIAGNOSTICS”‘]
Receive an email update when we add a new CANCER DIAGNOSTICS article.
The Latest on: Cancer diagnostics
[google_news title=”” keyword=”cancer diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer diagnostics
- In war-battered Gaza, residents grow angry with Hamason April 26, 2024 at 11:00 pm
As Hamas sticks to a hard line in cease-fire negotiations with Israel, many Palestinians just want the fighting and misery to end after more than six devastating months.
- King Charles to Resume Royal Duties After Cancer Diagnosison April 26, 2024 at 2:29 pm
King Charles III is set to resume public appearances for the first time after his cancer diagnosis and current medical treatment. “His Majesty The King will shortly return to public-facing duties ...
- A timeline of King Charles' health struggles, from his cancer diagnosis to his return to public dutieson April 26, 2024 at 2:05 pm
Months after King Charles III was diagnosed with cancer, he is set to return to public-facing duties to visit a cancer treatment center.
- King Charles to resume public royal duties after cancer diagnosison April 26, 2024 at 1:50 pm
Charles and his wife, Queen Camilla, will make a joint visit Tuesday to a cancer treatment center, marking his first public engagement in weeks. Several other events are scheduled, palace officials ...
- OCDE Superintendent Al Mijares announces retirement amid cancer diagnosison April 26, 2024 at 1:49 pm
After 12 years of serving as the Orange County Department of Education’s superintendent, Al Mijares will retire at the end of June. Mijares announced his retirement on Friday, April 26, citing medical ...
- King Charles to resume public duties after cancer diagnosison April 26, 2024 at 10:55 am
STORY: King Charles will return to public duties next week for the first time since he was diagnosed with cancer as he makes good progress following treatment and a period of recuperation, Buckingham ...
- King Charles Resuming Public Duties ‘Shortly,’ After Cancer Diagnosison April 26, 2024 at 10:46 am
King Charles announced his cancer diagnosis in February after receiving treatment for a benign prostate enlargement.
- King Charles III Returning to Public Duties After Cancer Diagnosison April 26, 2024 at 10:44 am
Nearly three months after King Charles III's cancer diagnosis, Buckingham Palace announced when the 75-year-old will return to public-facing duties.
- King Charles to Resume Public Duties After Cancer Diagnosis, Doctors Are ‘Very Encouraged by the Progress Made So Far’on April 26, 2024 at 10:09 am
King Charles is resuming public duties following his February cancer diagnosis. In a statement issued on Friday alongside a new photo of the King with his wife, Queen consort Camilla, Buckingham ...
via Bing News